Eisai
4523.T
#2011
Rank
A$12.47 B
Marketcap
$44.24
Share price
-0.53%
Change (1 day)
-37.86%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : A$5.22 Billion

According to Eisai's latest financial reports the company's total liabilities are A$5.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31A$4.92 B-3.58%
2022-03-31A$5.10 B18.44%
2021-03-31A$4.31 B-20.03%
2020-03-31A$5.39 B1.13%
2019-03-31A$5.33 B0.16%
2018-03-31A$5.32 B6.42%
2017-03-31A$5.00 B8.46%
2016-03-31A$4.61 B-6.14%
2015-03-31A$4.91 B5.38%
2014-03-31A$4.66 B-11.23%
2013-03-31A$5.25 B-22.24%
2012-03-31A$6.75 B-8.83%
2011-03-31A$7.41 B-6.7%
2010-03-31A$7.94 B-23.95%
2009-03-31A$10.44 B42.21%
2008-03-31A$7.34 B204.59%
2007-03-31A$2.41 B-12.1%
2006-03-31A$2.74 B11.83%
2005-03-31A$2.45 B-1.88%
2004-03-31A$2.50 B-12.52%
2003-03-31A$2.85 B9.09%
2002-03-31A$2.62 B-21.22%
2001-03-31A$3.32 B